⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RPRX News
Royalty Pharma plc Class A Ordinary Shares
$1.59 Billion PD-1 Resistant Head and Neck Cancer Market Analysis Report 2026: Size, Growth, and Segmentation Insights to 2030
globenewswire.com
CVM
EXEL
MRK
PFE
AZN
RPRX
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
globenewswire.com
RPRX
Royalty Pharma Announces Expansion of Leadership Team
globenewswire.com
RPRX
Application Security Market worth $66.03 billion by 2031 | MarketsandMarkets™
prnewswire.com
IBM
SNPS
CSCO
RPRX
GLXY
REDBREAST® IRISH WHISKEY AND ANDREW SCOTT RETURN TO SXSW TO UNCOVER CINEMATIC GEMS THROUGH 'REDBREAST UNHIDDEN'
prnewswire.com
RPRX
American Kidney Fund Brings Kidney Community Together March 2-5 for Seventh Annual Kidney Action Week
globenewswire.com
RPRX
NVS
TVTX
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
globenewswire.com
RPRX
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
globenewswire.com
RPRX
ZYME
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
globenewswire.com
RPRX
ZYME
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
globenewswire.com
RPRX